Jobs at Stylus Medicine

You will lead the computational strategy for engineering large serine recombinases (LSRs) and drive AI/ML-driven protein design to advance in vivo genetic medicines. You'll oversee a team spanning NGS and computational biology, build predictive models, and integrate multi-omics data to guide platform discovery and translation.

You'll lead analytical development strategy for in vivo genetic medicines at Stylus Medicine. You'll guide method development, qualification, and regulatory filings for drug substance and product. This role offers the chance to shape **potency assay strategy** and **analytical lifecycle management** across a transformative portfolio.

You will lead the development of scalable upstream microbial fermentation processes for nucleic acids and recombinant proteins. Your work will advance transformative in vivo genetic medicines by optimizing process performance, robustness, and tech transfer from bench to pilot scale.

You will lead computational analysis of NGS data from large serine recombinase experiments, build integrated workflows combining proprietary and public datasets, and design scalable pipelines for multi-omics analysis. Collaborating closely with wet-lab teams, you'll transform experimental data into insights that drive next-generation genetic medicine development.

You'll lead **NHP studies** for a cutting-edge **in vivo genetic medicines** company. You'll drive **study protocol design and CRO management** to advance transformative therapies.

You'll **lead genome engineering initiatives** to enhance recombinase activity for **therapeutic pipeline development**. Your work driving **high-throughput screening campaigns** will directly expand the frontiers of in vivo genetic medicine.